Necrotic cell death and ‘necrostatins’: now we can control cellular explosion
- 31 August 2008
- journal article
- review article
- Published by Elsevier BV in Trends in Biochemical Sciences
- Vol. 33 (8), 352-355
- https://doi.org/10.1016/j.tibs.2008.05.007
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Identification of RIP1 kinase as a specific cellular target of necrostatinsNature Chemical Biology, 2008
- The Cardioprotective Effect of Necrostatin Requires the Cyclophilin-D Component of the Mitochondrial Permeability Transition PoreCardiovascular Drugs and Therapy, 2007
- Cell death by necrosis: towards a molecular definitionTrends in Biochemical Sciences, 2007
- Necrosis, a well-orchestrated form of cell demise: Signalling cascades, important mediators and concomitant immune responseBiochimica et Biophysica Acta (BBA) - Bioenergetics, 2006
- Necrotic death as a cell fateGenes & Development, 2006
- Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injuryNature Chemical Biology, 2005
- Fas triggers an alternative, caspase-8–independent cell death pathway using the kinase RIP as effector moleculeNature Immunology, 2000
- Caspase-independent programmed cell death with necrotic morphologyCell Death & Differentiation, 1999
- Dual Signaling of the Fas Receptor: Initiation of Both Apoptotic and Necrotic Cell Death PathwaysThe Journal of Experimental Medicine, 1998
- The morphology of various types of cell death in prenatal tissuesTeratology, 1973